GFS Advisors, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
GFS Advisors, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$458,000
-6.0%
10,525
-5.9%
0.10%
+1.0%
Q1 2022$487,000
-9.3%
11,185
-8.2%
0.10%
+14.6%
Q4 2021$537,000
+27.3%
12,185
+10.4%
0.09%
-3.3%
Q3 2021$422,000
-3.9%
11,0350.0%0.09%
-7.1%
Q2 2021$439,000
+11.4%
11,0350.0%0.10%
+7.6%
Q1 2021$394,000
-3.0%
11,0350.0%0.09%
-14.0%
Q4 2020$406,000
-2.2%
11,0350.0%0.11%
-15.1%
Q3 2020$415,000
-7.8%
11,0350.0%0.13%
-9.4%
Q2 2020$450,000
+7.7%
11,0350.0%0.14%
+6.1%
Q1 2020$418,000
-16.7%
11,035
+3.3%
0.13%0.0%
Q4 2019$502,000
+10.1%
10,6850.0%0.13%
+3.1%
Q3 2019$456,000
-45.1%
10,685
-48.5%
0.13%
-46.2%
Q2 2019$831,000
-4.3%
20,7650.0%0.24%
-8.2%
Q1 2019$868,000
+2.5%
20,765
-6.3%
0.26%
+13.2%
Q4 2018$847,000
-4.9%
22,165
-0.0%
0.23%0.0%
Q3 2018$891,000
-20.1%
22,171
-19.8%
0.23%
-2.2%
Q2 2018$1,115,000
-7.5%
27,652
-10.4%
0.23%
-6.8%
Q1 2018$1,205,000
+23.7%
30,852
+12.4%
0.25%
+18.0%
Q4 2017$974,000
+42.8%
27,438
+63.3%
0.21%
+37.0%
Q3 2017$682,000
-6.2%
16,802
-0.4%
0.15%
-2.5%
Q2 2017$727,000
+58.7%
16,869
+55.2%
0.16%
+68.1%
Q1 2017$458,000
+124.5%
10,869
+105.2%
0.09%
+118.6%
Q4 2016$204,000
-10.5%
5,2960.0%0.04%
-15.7%
Q3 2016$228,000
-98.2%
5,296
-99.0%
0.05%
-45.7%
Q1 2016$12,797,000
+4165.7%
515,504
+6823.2%
0.09%
+5.6%
Q4 2015$300,000
+38.2%
7,446
+31.9%
0.09%
+18.7%
Q3 2015$217,0005,6460.08%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders